Before 1921, a type 1 diabetes diagnosis was terminal. It spelt a death sentence with few effective treatments. 2021 marks 100 years since the discovery of insulin… but how did we get there? If you had T1D,…
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission…
Prof Tom Kay is Director of St Vincent’s Institute of Medical Research in Melbourne, and Principal Investigator of the recently launched BANDIT clinical trial. BANDIT is looking at a drug…
Every 18 months, the Immunology of Diabetes Society (IDS) Congress brings together the world’s brightest scientific minds to discuss the latest progress in understanding and treating T1D. This year’s virtual…
Results from a recently completed JDRF clinical trial have shown some big benefits to hybrid closed-loop technology. Published in the journal Diabetes Care, the results come from a trial led…
The European Association for the Study of Diabetes (EASD) annual meeting brings together the top researchers from around the world to discuss the latest findings in diabetes research. This year,…
JDRF is pleased to announce the appointment of Prof Maria Craig in a new role as Medical Director of the Australasian Diabetes Data Network (ADDN). Prof Craig has a wealth…
You may have heard that getting a new T1D treatment or device to market can take around 12 to 15 years. This is because there’s a huge amount of work…
